Search for Clinical Trial Results

Sponsored By

Pfeiffer Syndrome - 5 Studies Found

Status Study
Terminated Study Name: Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
Condition: Medical Oncology
Date: 2015-02-16
Interventions: Drug: BAY1187982 A dose of 0.1 mg BAY 1187982 per kilogram (kg) body weight (BW) was chosen as the start
Recruiting Study Name: A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Condition: Advanced Cholangiocarcinoma
Date: 2014-05-12
Interventions: Drug: BGJ398 Capsule for oral use
Active, not recruiting Study Name: Phase 1/2 Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
Condition: Solid Tumor
Date: 2012-12-14
Interventions: Drug: ARQ 087 Subjects in this study will receive ARQ 087 orally at dose levels specified for their resp
Recruiting Study Name: Dovitinib for Gastric Cancer With FGFR2 Amplification
Condition: Gastric Cancer
Date: 2012-10-22
Interventions: Drug: Dovitinib
  • Study trea
Not yet recruiting Study Name: Pan FGFR Kinase Inhibitor BGJ398 in Treating Patients With FGFR1-3 Translocated, Mutated, or Amplified Recurrent Head and Neck Cancer
Condition:
  • FGFR Gene Amplification
  • FGFR1 Gene Amplification
  • Date: 2016-03-01
    Interventions:
    • Other: Laboratory Biomarker Analysis